Interestingly, a new classification of cancer has been proposed based on the pattern of T-cell infiltration and expression of PD-L1 [12] and four different tumor microenvironment phenotypes have been identified in association with the clinical response to anti-PD-L1 therapy. The gene discussed is CD274; the disease is neoplasm.